SFRP4 and prostate carcinoma: Specifically, experimental approaches, such as immunohistochemistry, quantitative PCR, or functional assays using prostate cancer and neural cell co-culture systems, could validate the biological relevance of hub genes identified in our study, such as SFRP4, ESR1, and others, in the context of perineural invasion.